Praveen Gundelly Yasuhiro Suzuki Julie A Ribes Alice Thornton
10.1155/2016/2737295
Biomed Res Int
2016;2016:2737295.
CC BY
https://pubmed.ncbi.nlm.nih.gov/27631004/
Actinomycetales Infections / immunology Actinomycetales Infections / microbiology Anti-Bacterial Agents / pharmacology Rhodococcus equi / drug effects Rhodococcus equi / isolation & purification
Actinomycetales Infections / immunology Actinomycetales Infections / microbiology Anti-Bacterial Agents / pharmacology Rhodococcus equi / drug effects Rhodococcus equi / isolation & purification Case Reports Actinomycetales Infections / drug therapy Actinomycetales Infections / mortality Adult Aged Anti-Bacterial Agents / therapeutic use Demography Female Humans Immunocompetence / drug effects Immunocompromised Host Male Microbial Sensitivity Tests Middle Aged Organ Specificity Anti-Bacterial Agents
PMC5007318
27631004
Differences in Rhodococcus equi Infections Based on Immune Status and Antibiotic Susceptibility of Clinical Isolates in a Case Series of 12 Patients and Cases in the Literature
2016